scispace - formally typeset
J

Jeffrey V. Ravetch

Researcher at Rockefeller University

Publications -  310
Citations -  59480

Jeffrey V. Ravetch is an academic researcher from Rockefeller University. The author has contributed to research in topics: Antibody & Receptor. The author has an hindex of 110, co-authored 296 publications receiving 54829 citations. Previous affiliations of Jeffrey V. Ravetch include Bristol-Myers Squibb & Kettering University.

Papers
More filters
Journal ArticleDOI

FcγRIII (CD16) on human macrophages is a functional product of the FcγRIII-2 gene

TL;DR: FcγRIII (CD16) on cultured monocytes is insensitive to phosphatidylinositol‐specific phospholipase C, is not allelic for the neutrophil NA alloantigens NA‐1/NA‐2, and functions to trigger cytotoxicity upon ligand binding.
Patent

Mice mutant for functional Fc receptors and method of treating autoimmune diseases

TL;DR: In this article, a non-naturally occurring non-human vertebrate animal incapable of expressing a functional Fc receptor which may optionally be expressing a protein which comprises a domain of a human Fc-RBP, as well as DNA encoding such Fc RBP-based proteins is described.
Journal ArticleDOI

Anti-retroviral antibody FcγR-mediated effector functions.

TL;DR: This review focuses on recent studies on broadly neutralizing anti‐HIV‐1 antibodies that revealed that Fc‐FcγR interactions are required to achieve full therapeutic activity through clearance of IgG‐opsonized virions and elimination of HIV‐infected cells.